赛升药业：关于公司控股股东、实际控制人的一致行动人减持股份的预披露公告

Core Viewpoint - The announcement from Sai Sheng Pharmaceutical indicates that two significant shareholders plan to reduce their holdings in the company within a specified timeframe, which may impact the stock's performance and investor sentiment [1] Shareholder Information - Ms. Ma Li holds 29,846,791 shares, representing 6.2% of the total share capital of 481,666,400 shares [1] - Ms. Liu Shuqin holds 8,748,000 shares, accounting for 1.82% of the total share capital [1] - Both Ms. Ma and Ms. Liu are acting in concert with the company's controlling shareholder, Mr. Ma Biao [1] Planned Share Reduction - Ms. Ma and Ms. Liu plan to reduce their holdings by a total of up to 9,633,328 shares, which is not more than 2% of the total share capital [1] - The reduction will occur within three months starting from 15 trading days after the announcement, specifically from October 21, 2025, to January 20, 2026 [1]